RAY B — RaySearch Laboratories AB (publ) Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Market Cap
SEK4.80bn
Enterprise Value
SEK4.99bn
Revenue
SEK1.02bn

Annual income statement for RaySearch Laboratories AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	742	652	642	844	1,022
Cost of Revenue
Gross Profit	669	608	591	749	916
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	673	655	695	801	907
Operating Profit	68.2	-3.47	-53.3	42.7	115
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	62.6	-6.48	-58.7	32.4	110
Provision for Income Taxes
Net Income After Taxes	50.4	-9.08	-47.3	23.8	81.6
Net Income Before Extraordinary Items
Net Income	50.4	-9.08	-47.3	23.8	81.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	50.4	-9.08	-47.3	23.8	81.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.47	-0.265	-1.38	0.694	2.38
Dividends per Share